Mulvihill, Erin E.
University of Ottawa · Ottawa Heart Institute
10 papers on CoChatORCID 0000-0002-3981-0241
Most cited papers
- Verified
GLP-1 Receptor Activation Indirectly Reduces Hepatic Lipid Accumulation But Does Not Attenuate Development of Atherosclerosis in Diabetic Male ApoE−/− Mice
Panjwani, N., Mulvihill, E. E., Longuet, C., Yusta, B., Campbell, J. E., Brown, T. J., Streutker, C., Holland, D., Cao, X., Baggio, L. L., et al. (2013) · Endocrinology
Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins
Cited by 346
- Verified
GLP-1 Receptor Expression Within the Human Heart
Baggio, L. L., Yusta, B., Mulvihill, E. E., Cao, X., Streutker, C. J., Butany, J., Cappola, T. P., Margulies, K. B., & Drucker, D. J. (2018) · Endocrinology
Diabetes Treatment and ManagementNeuropeptides and Animal Physiology
Cited by 312
- Verified
Citrus Flavonoids as Regulators of Lipoprotein Metabolism and Atherosclerosis
Mulvihill, E. E., Burke, A. C., & Huff, M. W. (2016) · Annual Review of Nutrition
Bioactive Compounds in PlantsPhytochemicals and Antioxidant Activities
Cited by 228
- Verified
TCF1 links GIPR signaling to the control of beta cell function and survival
Campbell, J. E., Ussher, J. R., Mulvihill, E. E., Kolic, J., Baggio, L. L., Cao, X., Liu, Y., Lamont, B. J., Morii, T., Streutker, C. J., et al. (2016) · Nature Medicine
Pancreatic function and diabetesDiabetes Treatment and Management
Cited by 142
- Verified
The autonomic nervous system and cardiac GLP-1 receptors control heart rate in mice
Baggio, L. L., Ussher, J. R., McLean, B. A., Cao, X., Kabir, M. G., Mulvihill, E. E., Mighiu, A. S., Zhang, H., Ludwig, A., Seeley, R. J., et al. (2017) · Molecular Metabolism
Diabetes Treatment and ManagementHeart Rate Variability and Autonomic Control
Cited by 117
- Verified
Distinct Neural Sites of GLP-1R Expression Mediate Physiological versus Pharmacological Control of Incretin Action
Varin, E. M., Mulvihill, E. E., Baggio, L. L., Koehler, J. A., Cao, X., Seeley, R. J., & Drucker, D. J. (2019) · Cell Reports
Regulation of Appetite and ObesityDiabetes Treatment and Management
Cited by 104
- Verified
Cellular Sites and Mechanisms Linking Reduction of Dipeptidyl Peptidase-4 Activity to Control of Incretin Hormone Action and Glucose Homeostasis
Mulvihill, E. E., Varin, E. M., Gladanac, B., Campbell, J. E., Ussher, J. R., Baggio, L. L., Yusta, B., Ayala, J., Burmeister, M. A., Matthews, D., et al. (2017) · Cell Metabolism
Diabetes Treatment and ManagementPeptidase Inhibition and Analysis
Cited by 102
- Verified
GLP-1 receptor agonist-based therapies and cardiovascular risk: a review of mechanisms
Mullur, N., Morissette, A., Morrow, N. M., & Mulvihill, E. E. (2024) · Journal of Endocrinology
Diabetes Treatment and ManagementPharmacology and Obesity Treatment
Cited by 51
- Verified
Regulation of intestinal lipid and lipoprotein metabolism by the proglucagon-derived peptides glucagon like peptide 1 and glucagon like peptide 2
Mulvihill, E. E. (2018) · Current Opinion in Lipidology
Lipid metabolism and disordersDiabetes Treatment and Management
Cited by 29
- Verified
Obesity management for the treatment of type 2 diabetes: emerging evidence and therapeutic approaches
Morissette, A., & Mulvihill, E. E. (2024) · Journal of Pharmacy & Pharmaceutical Sciences
Diabetes Treatment and ManagementPharmacology and Obesity Treatment
Cited by 8
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free